Drugs Made In America Acquisition Corp是一家总部位于美国的公司,从事行业运营。公司总部位于佛罗里达州劳德代尔堡。该公司于2025年1月28日首次公开募股(IPO)。Drugs Made In America Acquisition Corp是一家空白支票公司。该公司注册为免税公司,旨在与一个或多个企业进行合并、股份交换、资产收购、股份购买、资本重组、重组或其他类似业务合并。尽管该公司计划专注于在制药行业中寻找业务合并目标,但其寻找潜在目标企业的努力不限定于特定行业或地理区域。
DMAAU stock price ended at $10.58 on 星期三, after rising 1.44%
On the latest trading day Apr 08, 2026, the stock price of DMAAU rose by 1.44%, climbing from $10.57 to $10.58. During the session, the stock saw a volatility of 0.09%, with prices oscillating between a daily low of $10.57 and a high of $10.58. Notably, trading volume dropped by 2.8K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 2.9K shares were traded, equating to a market value of approximately $354.6M.